Nat Clin Pract Endocrinol Metab. 2006;2(9):474-475. J.V. Hennessey is an Associate Professor of Medicine at the Brown Medical School, Rhode Island Hospital, Providence, RI, USA. Disclosure: The ...

restart at lower dose. Myxedema coma: use IV levothyroxine. Adults: Monitor TSH 6–8 weeks after dose change then every 6–12 months when stable. Peds: Monitor TSH and total or free-T4 at 2 and ...

newcastle.ac.uk Seventy-six per cent of patients with SCH allocated to levothyroxine received a dose of 50 μg daily or less, with 12% taking 75 or 100 μg daily, and a further 12% discontinuing ...